

Cover Story
By Matthew Bin Han Ong
Nearly 100 cancer patients and others gather for a march to University of Utah President David Pershing's office on April 24, calling for the reinstatement of Mary Beckerle as director and CEO of the Huntsman Cancer Institute.Cover Photo by Scott G Winterton, Deseret NewsA week after her abrupt firing, Mary Beckerle is back in her job as director and CEO of the Huntsman Cancer Institute.
In Brief


Drugs & Targets


Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants














